Ata Mahmoodpoor
Overview
Explore the profile of Ata Mahmoodpoor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
215
Citations
1559
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naeimzadeh F, Sadeghi A, Saghaleini S, Sarbakhsh P, Mahmoodpoor A, Gharekhani A
Bioimpacts
. 2025 Feb;
15:30261.
PMID: 39963575
Introduction: Pro-inflammatory responses have an important role in developing coronavirus disease 2019 (COVID-19). L-carnitine (LC) has been known to possess anti-inflammatory, anticoagulant, and antiviral effects. So, we aimed to evaluate...
2.
Noshadi N, Sabet S, Sanaie S, Mahmoodpoor A, Tutunchi H, Naghshi S, et al.
Br J Nutr
. 2025 Jan;
1-25.
PMID: 39844647
The therapeutic effects of probiotics in patients with traumatic brain injury (TBI) remain unclear. This study aimed to investigate the effects of probiotic supplementation on cell adhesion molecules, oxidative stress,...
3.
Hosseini M, Sanaie S, Mahmoodpoor A, Jabbari Beyrami S, Jabbari Beyrami H, Fattahi S, et al.
Eur J Med Res
. 2024 Nov;
29(1):571.
PMID: 39614391
Xerostomia, generally addressed as dry mouth, poses significant challenges to patients' quality of life, particularly in the context of cancer treatment. Although various medications and interventions, including salivary substitutes and...
4.
Taccone F, Rynkowski C, Rynkowski Bittencourt C, Moller K, Lormans P, Quintana-Diaz M, et al.
JAMA
. 2024 Oct;
332(19):1623-1633.
PMID: 39382241
Importance: Blood transfusions are commonly administered to patients with acute brain injury. The optimal hemoglobin transfusion threshold is uncertain in this patient population. Objective: To assess the impact on neurological...
5.
Rahimi-Bashar F, Pandian V, Mahmoodpoor A, Probst S, Vahedian-Azimi A
Intensive Crit Care Nurs
. 2024 Sep;
86:103839.
PMID: 39303322
No abstract available.
6.
Abbaszadeh S, Yousefi M, Arefhosseini S, Mahmoodpoor A, Mameghani M
Sci Prog
. 2024 Aug;
107(3):368504241259299.
PMID: 39196597
Background: Inflammatory processes are key factors in pathological events associated with severe traumatic brain injury (STBI). The aim of this trial was to determine the effect of probiotics on anthropometric...
7.
Mahmoodpoor A, Chalkias A, Izadi M, Gohari-Moghadam K, Rahimi-Bashar F, Karadag A, et al.
Intensive Crit Care Nurs
. 2024 Aug;
86:103796.
PMID: 39117534
Objectives: To investigate the correlation between varying doses of norepinephrine (NE) and the incidence of pressure injuries (PIs) in COVID-19 patients in intensive care units (ICUs). Design: A retrospective multicenter...
8.
Khesht A, Karpisheh V, Saeed B, Zekiy A, Yapanto L, Nabi Afjadi M, et al.
Int Immunopharmacol
. 2024 Jul;
138:112594.
PMID: 39075740
No abstract available.
9.
Rezabakhsh A, Mojtahedi F, Tahsini Tekantapeh S, Mahmoodpoor A, Ala A, Soleimanpour H
Arch Acad Emerg Med
. 2024 Jul;
12(1):e47.
PMID: 38994467
Introduction: The COVID-19 pandemic caused by SARS-CoV-2 has been the major health concern in 2019 globally. Considering the severity and phase of the disease, various pharmacotherapy schedules were proposed. Here,...
10.
Balafar M, Mahmoodpoor A, Arjmandi H, Maddah Khelejani A, Soleimanpour H
Arch Acad Emerg Med
. 2024 Jul;
12(1):e41.
PMID: 38962363
No abstract available.